# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-05T11:58:10.523925
**Route:** OpenRouter + LaTeX
**Paper Hash:** d37fc45a2f2ba0c8
**Tokens:** 17350 in / 1494 out
**Response SHA256:** 96e2b54c7c013cbb

---

No fatal errors detected in the four categories you specified.

### Checks performed (fatal-error screen)

#### 1) Data–Design Alignment (critical)
- **Treatment timing vs. data coverage:** Treatment is the June **2017** election; main DiD codes **Post = 1(t ≥ 2018)**. Data used in regressions cover **2008–2017, 2020, 2023**, so treatment occurs within the data window and there are post-treatment observations (2020, 2023). No cohort is “treated after the data end.”
- **Post-treatment observations:** For the main DiD, post-treatment years exist (2020, 2023). For the event study, the paper is explicit that post-treatment coefficients are only for **+2 (2020)** and **+5 (2023)** due to missing usable OFGL years; that is coherent with the panel described.
- **Treatment definition consistency:** “Cumulard” is consistently defined as **XIV legislature deputy (2012–2017) simultaneously mayor**, and that is the regressor interacting with Post throughout.

#### 2) Regression Sanity (critical)
Checked all displayed regression tables:
- **Table 2 (Main DiD, \Cref{tab:main}):** Coefficients and SEs are in plausible ranges; no extreme SEs, no impossible R² values, no NA/NaN/Inf.
- **Table 3 (Robustness investment, \Cref{tab:robust_invest}):** Same—no broken outputs.
- **Appendix Table A3 (Triple-diff, \Cref{tab:triple_diff}):** Coefficients/SEs plausible; R² within [0,1].
- **Appendix Table A4 (HonestDiD bounds, \Cref{tab:honest_did}):** Values are finite and coherent.

No fatal regression-output red flags found.

#### 3) Completeness (critical)
- No placeholders like TBD/TODO/NA in tables where estimates should be.
- Regression tables report **Observations** and **standard errors**.
- Methods described (main DiD, event study, placebo, DGFiP-only, commune-level, triple-diff, HonestDiD) all have corresponding reported results either in main text tables/figures or appendix items.

#### 4) Internal Consistency (critical)
- Key numeric claims in text match the main table (e.g., investment effect −0.014; log investment −0.004).
- Timing is consistent: base year **2017** in event study; Post defined as **2018+** in main DiD; and the text acknowledges only 2020/2023 are observed post.
- One minor inconsistency exists but **not fatal** under your criteria: the paper variously describes OFGL coverage as “2017–2023” (title footnote) vs “2017–2024” (Data section). Since the analysis uses only 2020 and 2023 and nowhere relies on 2024, this does not create a design-data impossibility.

ADVISOR VERDICT: PASS